Press Releases Todos Medical Ltd.

Equities

TOMDF

IL0011392375

Market Closed - OTC Markets Other stock markets 01:07:29 2024-04-25 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-99.50%

2023	Todos Announces Notice of Allowance from Uspto for Patent Application Covering Use of Compositions in Tollovid?? and Tollovir?? Ingredients	CI
2023	Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Todos Medical Announces Insolvency Proceedings in Israel	Dec. 22	AQ
Todos Medical Provides Corporate Update, Retooling to Focus on Long COVID Epidemic	23-09-27	AQ
Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic	23-09-26	AQ
Todos Announces Notice of Allowance from USPTO for Patent Application Covering Use of Compositions in Tollovid and Tollovir Ingredients	23-08-31	AQ
Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients	23-08-30	AQ
CapitalGainsReport: Top Corona Stocks Watchlist (AXLA, BIXT, TOMDF, NVAX, MRNA)	23-08-30	AQ
TODOS MEDICAL LTD. : Entry into a Material Definitive Agreement (form 8-K)	23-03-31	AQ
Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics	23-03-28	AQ
Todos Medical Begins Trading on the OTC Pink Marketplace	23-03-27	AQ
Todos Medical Supports Long COVID Awareness Day	23-03-15	AQ
Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note Holders	23-03-13	AQ
Todos Medical Provides Corporate Update	23-02-23	AQ
Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics	23-02-14	AQ
Todos Medical to Present at the RHK 2022 Disruptive Growth Conference	22-12-06	AQ
Todos Medical's 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022	22-11-30	AQ
Todos Medical’s 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022	22-11-29	AQ
Todos Medical to Attend World Antiviral Congress	22-11-22	AQ
Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network	22-11-16	AQ
Todos Medical Announces Third Quarter 2022 Financial Results	22-11-15	AQ
Todos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022	22-11-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Todos Medical Ltd.

Equities

TOMDF

IL0011392375

Press Releases

Filters